IL1B and dry eye syndrome: Similar to the effects seen with DOPG, topical doxycycline in mouse models of dry eye reduces expression of IL-1α, IL-1β, and TNF-α, and in LPS-stimulated corneal epithelial cells, it has been shown to reduce IL-1β transcription and translation [41].